Literature DB >> 1975216

Selective release of N-acetylaspartylglutamate from rat optic nerve terminals in vivo.

G Tsai1, B L Stauch, J J Vornov, J K Deshpande, J T Coyle.   

Abstract

Glutamate (Glu) and aspartate (Asp) are considered to be the neurotransmitters of the optic pathway in submammalian species, but their roles in mammals is uncertain. Recently, N-acetylaspartylglutamate (NAAG) has been proposed as a neurotransmitter in mammalian optic pathway; however, the release of endogenous NAAG on stimulation of the optic pathway has not been demonstrated. Using an in vivo microdialysis technique, we now report that electrical stimulation of rat optic nerve markedly increased the extracellular concentration of NAAG but not Glu/Asp in superficial superior colliculus where retinal afferents terminate, whereas non-specific stimulation of neurotransmitter release by high potassium or veratridine increased both extracellular Glu/Asp and NAAG concentration in the perfusate. The release of NAAG was dependent on Ca2+ and the presence of optic terminals. We conclude that NAAG is a better candidate as a neurotransmitter of rat optic nerve terminals than Glu/Asp.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975216     DOI: 10.1016/0006-8993(90)90989-o

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Demonstration of cholinergic ganglion cells in rat retina: expression of an alternative splice variant of choline acetyltransferase.

Authors:  Osamu Yasuhara; Ikuo Tooyama; Yoshinari Aimi; Jean-Pierre Bellier; Tadashi Hisano; Akinori Matsuo; Masami Park; Hiroshi Kimura
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

2.  The effects of glutamate on spontaneous acetylcholine secretion processes in the rat neuromuscular synapse.

Authors:  A I Malomuzh; M R Mukhtarov; A Kh Urazaev; E E Nikol'skii; F Vyskochil
Journal:  Neurosci Behav Physiol       Date:  2002 Nov-Dec

3.  Modulation of GABAergic inhibition in the rat superior colliculus by a presynaptic group II metabotropic glutamate receptor.

Authors:  S A Neale; T E Salt
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

4.  Detection of increased urinary N-acetylaspartylglutamate in Canavan disease.

Authors:  A P Burlina; A Corazza; V Ferrari; P Erhard; B Künnecke; J Seelig; A B Burlina
Journal:  Eur J Pediatr       Date:  1994-07       Impact factor: 3.183

5.  N-acetylaspartic acid (NAA) and N-acetylaspartylglutamic acid (NAAG) in human ventricular, subarachnoid, and lumbar cerebrospinal fluid.

Authors:  K F Faull; R Rafie; N Pascoe; L Marsh; A Pfefferbaum
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

6.  Inhibition of glutamate-carboxypeptidase-II in dorsolateral prefrontal cortex: potential therapeutic target for neuroinflammatory cognitive disorders.

Authors:  Shengtao Yang; Dibyadeep Datta; Alvaro Duque; Yury M Morozov; Jon Arellano; Barbara S Slusher; Min Wang; Amy F T Arnsten
Journal:  Mol Psychiatry       Date:  2022-06-22       Impact factor: 13.437

7.  Amino acids and N-acetyl-aspartyl-glutamate as neurotransmitter candidates in the monkey retinogeniculate pathways.

Authors:  R Molinar-Rode; P Pasik
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

8.  Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.

Authors:  R E Carter; A R Feldman; J T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

Review 9.  Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.

Authors:  Zheng-Xiong Xi; Eliot L Gardner
Journal:  Curr Drug Abuse Rev       Date:  2008-11

10.  Effects of illumination and enucleation on substance-P-immunoreactive structures in subcortical visual centers of golden hamster and Wistar rat.

Authors:  M Hartwich; A Kalsbeek; P Pévet; F Nürnberger
Journal:  Cell Tissue Res       Date:  1994-08       Impact factor: 5.249

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.